GlaxoSmithKline PLC — Director's Dealing 2020

Jun 16, 2020

National Storage Mechanism | Additional information

RNS Number : 1349Q

GlaxoSmithKline PLC

16 June 2020

GlaxoSmithKline plc (the 'Company')

Transaction notification

1.

Details of PDMR/person closely associated with them ('PCA')

a)

Name

Mr P Thomson

b)

Position/status

President, Global Affairs

c)

Initial notification/

amendment

Initial notification

2.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

GlaxoSmithKline plc

b)

LEI

5493000HZTVUYLO1D793

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

a)

Description of the financial instrument

Ordinary shares of 25 pence each ('Ordinary Shares')

ISIN: GB0009252882

b)

Nature of the transaction

Acquisition of Ordinary Shares following the exercise of options granted on 30 November 2016 at the option price of £12.95 per Ordinary Share under the Company's ShareSave Plan. 

c)

Price(s) and volume(s)

Price(s)	Volume(s)
£12.95	277

d)

Aggregated information

Aggregated volume Price

N/A (single transaction)

e)

Date of the transaction

2020-06-12

f)

Place of the transaction

London Stock Exchange (XLON)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHFQLFFBQLZBBQ